| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/02/2003 | EP1298131A1 Quinolonecarboxylic acid derivative |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1298116A1 Process for preparing alkanesulfonyl pyridines |
| 04/02/2003 | EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 04/02/2003 | EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 04/02/2003 | EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296959A1 Methods and compositions utilizing quinazolinones |
| 04/02/2003 | EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 04/02/2003 | EP1296953A2 Methods and compounds for inhibiting mrp1 |
| 04/02/2003 | EP1296950A2 Aminopiperidines for use as glyt-1 inhibitors |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 04/02/2003 | EP1296674A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 04/02/2003 | EP1296661A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 04/02/2003 | EP1204668B1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
| 04/02/2003 | EP1135386B1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 04/02/2003 | EP1121108B1 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/02/2003 | EP0991643B1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/02/2003 | EP0986387B1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0946520B1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0862560B1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 04/02/2003 | EP0587800B1 Immunomodulatory azaspiranes |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1407973A Butyne diol derivatives |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104428C Substitued benzocycloheptapyridine useful ad inhibitors of Farnesyl protein transferase |
| 04/02/2003 | CN1104427C Tricyclic inhibitors of farnesyl protein transferase |
| 04/02/2003 | CN1104424C Triazolyl disulphides |
| 04/02/2003 | CN1104419C Benzazepine derivatives with vasopressin agonistic activity |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541655 Catalytic compositions and methods for asymmetric allylic alkylation |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541491 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | CA2273951C Parasiticidal pyrazoles |
| 04/01/2003 | CA2066641C Picolinic acid derivative, method for preparing the same and herbicidal composition |
| 03/28/2003 | CA2405328A1 Process for preparing alkanesulfonyl pyridines |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024969A1 Tyrosine kinase inhibitors |
| 03/27/2003 | WO2003024957A1 Benzimidazole derivatives |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024934A2 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
| 03/27/2003 | WO2003024931A1 Tyrosine kinase inhibitors |
| 03/27/2003 | WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 03/27/2003 | WO2003024926A2 Methods and compositions of novel triazine compounds |
| 03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 03/27/2003 | WO2003024453A1 Excitatory amino acid receptor antagonists |
| 03/27/2003 | WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024447A1 Inhibitors of glycogen synthase kinase-3 |
| 03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
| 03/27/2003 | WO2003024386A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 03/27/2003 | WO2003024220A1 Delta 1-pyrrolines used as pesticides |
| 03/27/2003 | WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/27/2003 | WO2002101007A3 Antipathogenic benzamide compounds |
| 03/27/2003 | WO2002078628A3 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors |
| 03/27/2003 | WO2002060879A3 Bacterial gyrase inhibitors and uses thereof |
| 03/27/2003 | WO2002034727A3 Treatment of gastrointestinal stromal tumors |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/27/2003 | WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 03/27/2003 | US20030060631 An amine substituent at the 7-position of the quinolone-carboxylic acid derivative is produced; bactericides |
| 03/27/2003 | US20030060629 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/27/2003 | US20030060626 Fungicides |
| 03/27/2003 | US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative |
| 03/27/2003 | US20030060531 Do not require solvent to provide a system having suitable viscosity for convenient handling; rapid cure; adhesively attaching a microelectronic device to a substrate; die-attach paste |
| 03/27/2003 | US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain |
| 03/27/2003 | US20030060494 Dipeptidyl peptidase IV inhibiting agent; treatment of gastrointestinal disorders |
| 03/27/2003 | US20030060474 A piperazine compound as antithrombotic agent |
| 03/27/2003 | US20030060471 Pyrazle derivative, production process thereof, and pest control agent containing the same as ative ingredient |
| 03/27/2003 | US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them |
| 03/27/2003 | US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders |
| 03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
| 03/27/2003 | US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death |
| 03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
| 03/27/2003 | US20030060450 Such as 4-(3-chlorophenyl)-6-((4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl) -methyl)-1-methyl-2(1H)quinoline for treating mammalian tumors via inhibiting farnesyl transferase |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |